| Title : Targeting Neuroinflammation and Cognitive Decline: First-in-Class Dual Butyrylcholinesterase and p38alpha Mitogen-Activated Protein Kinase Inhibitors - Ferjancic Benetik_2025_J.Med.Chem__ |
| Author(s) : Ferjancic Benetik S , Proj M , Knez D , Kosak U , Meden A , Krajsek K , Pislar A , Horvat S , Svajger U , Tesic N , Pulkrabkova L , Soukup O , Skarka A , Andrys R , Brazzolotto X , Igert A , Nachon F , Dias J , Detka J , Gdula-Argasinska J , Wyska E , Szafarz M , Manik A , Plachtij N , Musilek K , Salat K , Obreza A , Gobec S |
| Ref : Journal of Medicinal Chemistry , : , 2025 |
| Abstract : |
| PubMedSearch : Ferjancic Benetik_2025_J.Med.Chem__ |
| PubMedID: 40779804 |
| Title : Targeting Neuroinflammation and Cognitive Decline: First-in-Class Dual Butyrylcholinesterase and p38alpha Mitogen-Activated Protein Kinase Inhibitors - Ferjancic Benetik_2025_J.Med.Chem__ |
| Author(s) : Ferjancic Benetik S , Proj M , Knez D , Kosak U , Meden A , Krajsek K , Pislar A , Horvat S , Svajger U , Tesic N , Pulkrabkova L , Soukup O , Skarka A , Andrys R , Brazzolotto X , Igert A , Nachon F , Dias J , Detka J , Gdula-Argasinska J , Wyska E , Szafarz M , Manik A , Plachtij N , Musilek K , Salat K , Obreza A , Gobec S |
| Ref : Journal of Medicinal Chemistry , : , 2025 |
| Abstract : |
| PubMedSearch : Ferjancic Benetik_2025_J.Med.Chem__ |
| PubMedID: 40779804 |
| Title : Transforming ureas into carbamates: From allosteric p38alpha MAPK ligands to dual BChE\/p38alpha MAPK inhibitors - Ferjancic Benetik_2025_Bioorg.Chem_165_108998 |
| Author(s) : Benetik SF , Meden A , Knez D , Mastnak-Sokolov P , Kosak U , Horvat S , Pislar A , Andrys R , Musilek K , Detka J , Salat K , Obreza A , Gobec S |
| Ref : Bioorg Chem , 165 :108998 , 2025 |
| Abstract : |
| PubMedSearch : Ferjancic Benetik_2025_Bioorg.Chem_165_108998 |
| PubMedID: 40987175 |
| Gene_locus related to this paper: human-BCHE |
| Title : Transforming ureas into carbamates: From allosteric p38alpha MAPK ligands to dual BChE\/p38alpha MAPK inhibitors - Ferjancic Benetik_2025_Bioorg.Chem_165_108998 |
| Author(s) : Benetik SF , Meden A , Knez D , Mastnak-Sokolov P , Kosak U , Horvat S , Pislar A , Andrys R , Musilek K , Detka J , Salat K , Obreza A , Gobec S |
| Ref : Bioorg Chem , 165 :108998 , 2025 |
| Abstract : |
| PubMedSearch : Ferjancic Benetik_2025_Bioorg.Chem_165_108998 |
| PubMedID: 40987175 |
| Gene_locus related to this paper: human-BCHE |
| Title : Targeting Neuroinflammation and Cognitive Decline: First-in-Class Dual Butyrylcholinesterase and p38alpha Mitogen-Activated Protein Kinase Inhibitors - Ferjancic Benetik_2025_J.Med.Chem__ |
| Author(s) : Ferjancic Benetik S , Proj M , Knez D , Kosak U , Meden A , Krajsek K , Pislar A , Horvat S , Svajger U , Tesic N , Pulkrabkova L , Soukup O , Skarka A , Andrys R , Brazzolotto X , Igert A , Nachon F , Dias J , Detka J , Gdula-Argasinska J , Wyska E , Szafarz M , Manik A , Plachtij N , Musilek K , Salat K , Obreza A , Gobec S |
| Ref : Journal of Medicinal Chemistry , : , 2025 |
| Abstract : |
| PubMedSearch : Ferjancic Benetik_2025_J.Med.Chem__ |
| PubMedID: 40779804 |
| Title : Transforming ureas into carbamates: From allosteric p38alpha MAPK ligands to dual BChE\/p38alpha MAPK inhibitors - Ferjancic Benetik_2025_Bioorg.Chem_165_108998 |
| Author(s) : Benetik SF , Meden A , Knez D , Mastnak-Sokolov P , Kosak U , Horvat S , Pislar A , Andrys R , Musilek K , Detka J , Salat K , Obreza A , Gobec S |
| Ref : Bioorg Chem , 165 :108998 , 2025 |
| Abstract : |
| PubMedSearch : Ferjancic Benetik_2025_Bioorg.Chem_165_108998 |
| PubMedID: 40987175 |
| Gene_locus related to this paper: human-BCHE |
| Title : Dual inhibition of butyrylcholinesterase and p38alpha mitogen-activated protein kinase: A new approach for the treatment of Alzheimer's disease - Ferjancic Benetik_2024_Pharmacol.Ther__108748 |
| Author(s) : Ferjancic Benetik S , Knez D , Obreza A , Kosak U , Gobec S |
| Ref : Pharmacol Ther , :108748 , 2024 |
| Abstract : |
| PubMedSearch : Ferjancic Benetik_2024_Pharmacol.Ther__108748 |
| PubMedID: 39521443 |
| Title : Dual inhibition of butyrylcholinesterase and p38alpha mitogen-activated protein kinase: A new approach for the treatment of Alzheimer's disease - Ferjancic Benetik_2024_Pharmacol.Ther__108748 |
| Author(s) : Ferjancic Benetik S , Knez D , Obreza A , Kosak U , Gobec S |
| Ref : Pharmacol Ther , :108748 , 2024 |
| Abstract : |
| PubMedSearch : Ferjancic Benetik_2024_Pharmacol.Ther__108748 |
| PubMedID: 39521443 |
| Title : Dual inhibition of butyrylcholinesterase and p38alpha mitogen-activated protein kinase: A new approach for the treatment of Alzheimer's disease - Ferjancic Benetik_2024_Pharmacol.Ther__108748 |
| Author(s) : Ferjancic Benetik S , Knez D , Obreza A , Kosak U , Gobec S |
| Ref : Pharmacol Ther , :108748 , 2024 |
| Abstract : |
| PubMedSearch : Ferjancic Benetik_2024_Pharmacol.Ther__108748 |
| PubMedID: 39521443 |